Keratin 20 - A diagnostic and prognostic marker in colorectal cancer?

Histology and Histopathology

Volumn 27, Issue 3, 2012, Pages 347-356

  Harbaum, Lars ^a   Pollheimer, Marion J ^a   Kornprat, Peter ^a   Lindtner, Richard A ^a   Schlemmer, Andrea ^a   Rehak, Peter ^a   Langner, Cord ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Carcinoma of unknown primary; Colorectal carcinoma; Keratin 20; Keratin 7; Prognosis

Indexed keywords

CYTOKERATIN 20; CYTOKERATIN 7; KRT20 PROTEIN, HUMAN; KRT7 PROTEIN, HUMAN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; TUMOR MARKER;

ARTICLE; AUSTRIA; CANCER GRADING; CANCER INVASION; CANCER STAGING; CARCINOMA; CELL DIFFERENTIATION; CHEMISTRY; CHI SQUARE DISTRIBUTION; COLORECTAL TUMOR; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; METASTASIS; MISMATCH REPAIR; MORTALITY; PATHOLOGY; PREDICTIVE VALUE; TIME; TISSUE MICROARRAY; TREATMENT OUTCOME; TUMOR VOLUME;

AUSTRIA; CARCINOMA; CELL DIFFERENTIATION; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; DNA MISMATCH REPAIR; DNA REPAIR ENZYMES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KERATIN-20; KERATIN-7; MALE; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; TIME FACTORS; TISSUE ARRAY ANALYSIS; TREATMENT OUTCOME; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84857753342     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bahrami A., Truong L.D. and Ro J.Y. (2008). Undifferentiated tumor: true identity by immunohistochemistry. Arch. Pathol. Lab. Med. 132, 326-348.
2. Bressenot A. and Zimmer O. (2008). CK20/CK7 protein expression in colorectal cancer: a marker for progression of colorectal cancer. Hum. Pathol. 39, 1714.
3. Chu P., Wu E. and Weiss L.M. (2000). Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod. Pathol. 13, 962-972.
4. Dennis J.L., Hvidsten T.R., Wit E.C., Komorowski J., Bell A.K., Downie I., Mooney J., Verbeke C., Bellamy C., Keith W.N. and Oien K.A. (2005). Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin. Cancer Res. 11, 3766-3772.
5. Goldstein N.S. and Bosler D. (2007). An approach to interpreting immunohistochemical stains of adenocarcinoma in small needle core biopsy specimens: the impact of limited specimen size. Am. J. Clin. Pathol. 127, 273-281.
6. Hamilton S.R., Vogelstein B. and Kudo S. (2000). Carcinoma of the colon and rectum. In: World health organization classification of tumours. Pathology and genetics. Tumours of the digestive system. Hamilton S.R. and Aaltonen L.A. (eds). IARC Press. Lyon. pp 105-119.
7. Harbaum L., Pollheimer M.J., Kornprat P., Lindtner R.A., Schlemmer A., Rehak P. and Langner C. (2011). Keratin 7 Expression in Colorectal Cancer - Freak of Nature or Significant Finding? Histopathology 59, 225-234.
8. Hernandez B.Y., Frierson H.F., Moskaluk C.A., Li Y.J., Clegg L., Cote T.R., McCusker M.E., Hankey B.F., Edwards B.K. and Goodman M.T. (2005). CK20 and CK7 protein expression in colorectal cancer: demonstration of the utility of a population-based tissue microarray. Hum. Pathol. 36, 275-281.
9. Hintze J. (2007). NCSS 2007. NCSS, LLC. USA. www.ncss.com.
10. Kende A.J., Carr N.J. and Sobin L.H. (2003). Expression of cytokeratins 7 and 20 in carcinomas of the gastrointestinal tract. Histopathology 42, 137-140.
11. Kononen J., Bubendorf L., Kallioniemi A., Bärlund M., Schraml P., Leighton S., Torhorst J., Mihatsch M.J., Sauter G. and Kallioniemi O.P. (1998). Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4, 844-847.
12. Kummar S., Fogarasi M., Canova A., Mota A. and Ciesielski T. (2002). Cytokeratin 7 and 20 staining for the diagnosis of lung and colorectal adenocarcinoma. Br. J. Cancer 86, 1884-1887.
13. Lassmann S., Bauer M., Schreglmann J., Tabiti K., Nährig J., Rüger R., Höfler H. and Werner M. (2002). Quantification of CK20 gene and protein expression incolorectal cancer by RT-PCR and immunohistochemistry reveals inter- and intratumour heterogeneity. J. Pathol. 198, 198-206.
14. Lugli A., Tzankov A., Zlobec I. and Terracciano L.M. (2008). Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status. Mod. Pathol. 21, 1403-1412.
15. McGregor D.K., Wu T.T., Rashid A., Luthra R. and Hamilton S.R. (2004). Reduced expression of cytokeratin 20 in colorectal carcinomas with high levels of microsatellite instability. Am. J. Surg. Pathol. 28, 712-718.
16. Moertel C.G., Fleming T.R., MacDonald J.S., Haller D.G., Laurie J.A., Goodman P.J., Ungerleider J.S., Emerson W.A., Tormey D.C. and Glick J.H. (1990). Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N. Engl. J. Med. 322, 352-358.
17. Park S.Y., Kim H.S., Hong E.K. and Kim W.H. (2002). Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary. Hum. Pathol. 33, 1078-1085.
18. Park S.Y., Kim B.H., Kim J.H., Lee S. and Kang G.H. (2007). Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma. Arch. Pathol. Lab. Med. 131, 1561-1567.
19. Sobin L.H. and Wittekind C. (2002). TNM Classification of malignant tumors. Wiley-Liss inc. New York.
20. Tatsumi N., Kushima R., Vieth M., Mukaisho K., Kakinoki R., Okabe H., Borchard F., Stolte M., Okanoue T. and Hattori T. (2006). Cytokeratin 7/20 and mucin core protein expression in ulcerative colitis-associated colorectal neoplasms. Virchows Arch. 448, 756-762.
21. Tot T. (1999). Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors. Cancer 85, 171-177.
22. Tot T. and Samii S. (2003). The clinical relevance of cytokeratin phenotyping in needle biopsy of liver metastasis. APMIS 111, 1075-1082.
23. Ueno H., Murphy J., Jass J.R., Mochizuki H. and Talbot I.C. (2002). Tumor 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40, 127-132.
24. Varadhachary G.R., Raber M.N., Matamoros A. and Abbruzzese J.L. (2008). Carcinoma of unknown primary with a colon-cancer profilechanging paradigm and emerging definitions. Lancet Oncol. 9, 596-599.
25. Wang N.P., Zee S., Zarbo R.J., Bacchi C.E. and Gown A.M. (1995). Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl. Immunohistochem. 3, 99-107.